I'm Head of Innovation for R&D Quality at a global pharma company in Germany, where I build the AI governance frameworks that decide whether a tool ships or dies in validation. Clinical pharmacist by training (Coimbra, Portugal), now operating at the intersection almost nobody sits at - close enough to the regulators to know what Annex 22 actually demands, close enough to the builders to know why most governance frameworks get quietly ignored. I write Trust Architecture, a newsletter about the operational layer of AI governance - the part that comes after the policy PDF and before anyone actually trusts the thing. Book me if you're standing in front of a regulated AI deployment wondering why adoption stalled, why your validation passed but nobody uses the tool, or whether your governance is real or theatre. I've made all three mistakes. That's why I'm useful. Views expressed are personal and independent.